SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
18614972
Source:
http://linkedlifedata.com/resource/pubmed/id/18614972
Search
Subject
(
53
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0001617
,
umls-concept:C0557854
,
umls-concept:C0666743
,
umls-concept:C1524063
,
umls-concept:C1527392
pubmed:issue
3
pubmed:dateCreated
2008-7-10
pubmed:abstractText
Third-level Day-Hospital Services of Gastro-Hepatology are likely to recruit patients with an increased disease severity. The burden of request for immunomodulation drugs is presently unclear.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9109791
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Glucocorticoids
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunologic Factors
,
http://linkedlifedata.com/resource/pubmed/chemical/infliximab
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1121-421X
pubmed:author
pubmed-author:ActisG CGC
,
pubmed-author:BugianesiEE
,
pubmed-author:LaggetMM
,
pubmed-author:PellicaniLL
,
pubmed-author:RizzettoMM
pubmed:issnType
Print
pubmed:volume
54
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
239-42
pubmed:meshHeading
pubmed-meshheading:18614972-Adult
,
pubmed-meshheading:18614972-Anti-Inflammatory Agents
,
pubmed-meshheading:18614972-Antibodies, Monoclonal
,
pubmed-meshheading:18614972-Colitis, Ulcerative
,
pubmed-meshheading:18614972-Crohn Disease
,
pubmed-meshheading:18614972-Day Care
,
pubmed-meshheading:18614972-Drug Therapy, Combination
,
pubmed-meshheading:18614972-Female
,
pubmed-meshheading:18614972-Gastrointestinal Diseases
,
pubmed-meshheading:18614972-Glucocorticoids
,
pubmed-meshheading:18614972-Hepatitis, Autoimmune
,
pubmed-meshheading:18614972-Hospitals, Teaching
,
pubmed-meshheading:18614972-Humans
,
pubmed-meshheading:18614972-Immunologic Factors
,
pubmed-meshheading:18614972-Male
,
pubmed-meshheading:18614972-Medical Records
,
pubmed-meshheading:18614972-Middle Aged
,
pubmed-meshheading:18614972-Retrospective Studies
,
pubmed-meshheading:18614972-Treatment Outcome
pubmed:year
2008
pubmed:articleTitle
Use of corticosteroids, immunomodulators, and infliximab at a third-level Day-Hospital Service of Gastro-Hepatology.
pubmed:affiliation
Department of Gastro-Hepatology, Molinette Hospital, Turin, Italy. actis_g@libero.it
pubmed:publicationType
Journal Article